Alopecia, Androgenetic

Dermatology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Kimia Therapeutics
Kimia TherapeuticsCA - Berkeley
1 program
1
Non-concentrated adipose-derived stem cell conditioned media and 5% MinoxidilPhase 31 trial
Active Trials
NCT05296863CompletedEst. Dec 2021
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
Biometrological measurementsN/A1 trial
Active Trials
NCT06854432Terminated46Est. Apr 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Kimia TherapeuticsNon-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil
Pierre FabreBiometrological measurements

Clinical Trials (2)

Total enrollment: 46 patients across 2 trials

NCT05296863Kimia TherapeuticsNon-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

Start: Oct 2021Est. completion: Dec 2021
Phase 3Completed
NCT06854432Pierre FabreBiometrological measurements

Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia

Start: Mar 2024Est. completion: Apr 202446 patients
N/ATerminated

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
10h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
10h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
11h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
11h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
16h ago

Senior Manager, HTA, Value and Evidence (HV&E), Medical Dermatology

Pfizer
United States - New York - New York City
Yesterday
$139K - $232K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)